Microbial metabolitesnotably short-chain fatty acids (SCFAs) like butyrate and propionatestimulate L-cells to produce GLP-1 naturally (Tolhurst et al., 2012)
Some people may experience immediate benefits, while others may notice improvements over several weeks or months
Thus, the Work Group concluded that there is insufficient evidence to recommend use of vitamin C (ascorbate) in the management of anemia in patients with CKD

GHK-Cu Monitoring Schedule: Labs & Exams You Need At a glance Drug / GHK-Cu is a tripeptide-copper(II) complex first isolated from human plasma albumin Route / subcutaneous injection or topical (compounded under FDA section 503A) Baseline labs / serum copper, ceruloplasmin, CBC with differential, CMP including liver enzymes Recheck interval / 4 weeks after initiation, then every 8 to 12 weeks Normal serum copper / 70 to 140 g/dL (11 to 22 mol/L) Ceruloplasmin target / 20 to 35 mg/dL Liver enzymes / ALT and AST should remain below 2x upper limit of normal 24-hour urine copper / ordered if serum copper exceeds 155 g/dL on two consecutive draws Skin exam / baseline and every 12 weeks for subcutaneous injection sites Discontinuation trigger / serum copper above 200 g/dL or ceruloplasmin below 15 mg/dL How GHK-Cu Works: Mechanism Before Monitoring GHK-Cu is glycyl-L-histidyl-L-lysine bound to a single copper(II) ion
At steady state, this sum converges to a predictable range
Moreover, no established strategies exist to locally modulate iron efflux through FPN1 or hepcidin in OA joints